If the MHRA wanted to dismiss the DCVax-L framework, they could have done so quietly, months ago. Instead, they opened a public comment period about how to support exactly this kind of design during a live, high-profile application.
That’s not a coincidence. That’s prep work. Im very confident that DCVAXL will be approved albeit NWBO played it very risky tbh
Market Data 
Markets 
AI
